MELOXICAM TABLETS
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency awarded contract SPE2DP22F5070 to DMS Pharmaceutical Group Inc for the procurement of Meloxicam Tablets under the broader delivery order SPE2DX15D9383. While the overarching commercial items contract dated April 30, 2015, carried a total award value of 4,999,999.00 dollars and included specific FAR clauses and DPAS rating requirements, this particular award notice was posted on August 25, 2026. Subsequent to the award, Modification P00001 was issued by DLA Troop Support to effectuate a total cancellation of CLIN 0001 for the Meloxicam Tablets. This action was taken because the delivery orders were aged and unperformed, and the associated ships were being decommissioned. This modification decreased the contract amount by 6.02 dollars, resulting in a final total contract value of 0.00 dollars.
General Info
Place of Performance
Not specifiedSet-Aside
Documents
2AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
